2022 International Congress Archives - Page 110 of 153

Pilot study to investigate the use of in-clinic sensing to identify optimal stimulation parameters for deep brain stimulation therapy in Parkinson’s disease

S. Lewis, S. Ojemann, D. Kramer, L. Hirt, E. Radcliffe, M. Case, A. Becker, R. Raike, J. Thompson, D. Kern (Boulder, USA)
Ping Pong as a sport-based intervention to increase physical activity in people with Parkinson’s Disease

J. Domingos, J. Fernandes, J. Dean, C. Godinho (Monte de Caparica, Portugal)
PLA2G6-related dystonia-parkinsonism in identical twins manifesting at an advanced age: a case report and review of the literature.

D. Sugar, K. Kompoliti (Chicago, USA)
Plasma Alzheimer’s disease biomarkers and cognitive progression in Parkinson’s disease

A. Pilotto, NJ. Ashton, A. Lupini, B. Battaglio, S. Gipponi, E. Cottini, I. Grossi, A. Salvi, G. de Petro, M. Pizzi, K. Blennov, M. Gonzalez, D. Aarsland, H. Zetterberg, A. Padovani (Brescia, Italy)
Plasma biomarkers of disease progression in Parkinson’s disease

A. Lupini, N. Ashton, A. Pilotto, B. Battaglio, C. Zatti, S. Gipponi, E. Cottini, I. Grossi, A. Salvi, G. de Petro, M. Pizzi, K. Blennow, H. Zetterberg, A. Padovani (Brescia, Italy)
Plasma p-Tau181 and p-Tau231 in Parkinson’s Disease

MC. Gonzalez, NJ. Ashton, A. Pilitto, A. Padovani, B. Fernandes Gomes, DA. Tovar-Rios, F. Blanc, A. Lemstra, C. Paquet, C. Abdelnour, M. Boada, L. Bonanni, R. Vandenberghe, K. Blennow, H. Zetterberg, D. Aarsland (Stavanger, Norway)
Plasma p-tau181 is increased in Lewy body dementia and relates to cognitive performance

N. Hannaway, A. Heslegrave, R. Bhome, I. Dobreva, H. Zetterberg, R. Weil (LONDON, United Kingdom)
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

L. Batzu, S. Rota, A. Hye, A. Heslegrave, D. Trivedi, L. Gibson, C. Farrell, P. Zinzalias, A. Rizos, H. Zetterberg, K. Ray Chaudhuri, D. Aarsland (London, United Kingdom)
Polymorphisms in Prosaposin gene are associated with familial and early-onset Parkinson’s disease: A case-control association study and meta-analysis

YT. Chu, MC. Kuo, YA. Su, RM. Wu (Taipei, Taiwan)
Polypharmacy and drug-related problems in geriatric patients with Parkinson’s Disease

PV. Menon, CY. Lee, CH. Tan, S. Kumar Seetharaman (Singapore, Singapore)